GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Gross Profit

ARGX (argenx SE) Gross Profit : $1,665 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Gross Profit?

argenx SE's gross profit for the three months ended in Sep. 2024 was $514 Mil. argenx SE's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was $1,665 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. argenx SE's gross profit for the three months ended in Sep. 2024 was $514 Mil. argenx SE's Revenue for the three months ended in Sep. 2024 was $573 Mil. Therefore, argenx SE's Gross Margin % for the quarter that ended in Sep. 2024 was 89.69%.

argenx SE had a gross margin of 89.69% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of argenx SE was 92.83%. The lowest was 89.55%. And the median was 91.61%.


argenx SE Gross Profit Historical Data

The historical data trend for argenx SE's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Gross Profit Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.46 41.24 497.28 381.32 1,108.48

argenx SE Quarterly Data
Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 293.79 367.36 357.82 425.25 514.16

Competitive Comparison of argenx SE's Gross Profit

For the Biotechnology subindustry, argenx SE's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Gross Profit distribution charts can be found below:

* The bar in red indicates where argenx SE's Gross Profit falls into.



argenx SE Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

argenx SE's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1226.316 - 117.835
=1,108

argenx SE's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=573.236 - 59.072
=514

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,665 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

argenx SE's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=514 / 573.236
=89.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


argenx SE  (NAS:ARGX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

argenx SE had a gross margin of 89.69% for the quarter that ended in Sep. 2024 => Durable competitive advantage


argenx SE Gross Profit Related Terms

Thank you for viewing the detailed overview of argenx SE's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.